Charlotte Round Table - April 14, 2018

Charlotte Round Table - April 14, 2018
Event Description
On April 14, 2018, a Myeloma Crowd Round Table meeting was held in Charlotte, NC featuring three myeloma experts, including:
- Dr. Adam Cohen, Abramson Cancer Center, University of Pennsylvania
- Dr. Peter Voorhees, Levine Cancer Institute, Charlotte, NC
- Dr. Saad Usmani, Levine Cancer Institute, Charlotte, NC
Thanks to our Sponsors
Charlotte Round Table, April 14, 2018
MCRT Review
Speakers & Moderators

Adam D. Cohen, MD, is Director of the Myeloma Immunotherapy program and Associate Professor, Hematology/Oncology Division at the Abramson Cancer Center of the University of Pennsylvania in Philadelphia. He is recognized as one of the world’s leading experts in CAR T cell research and treatment in myeloma. Dr. Cohen is board certified in internal medicine, medical oncology, and hematology. He is a member of the American College of Physicians, American Society of Clinical Oncology, American Association for Cancer Research, American Society for Blood and Marrow Transplantation, and the American Society of Hematology. He is also a member of the Multiple Myeloma Committee, Eastern Cooperative Oncology Group and the Multiple Myeloma Panel, National Comprehensive Cancer Network. In addition, Dr. Cohen is an ad hoc reviewer for Annals of Oncology, Cytotherapy, Journal of Translational Medicine, Blood, Amyloid, and Clinical Cancer Research. He has written dozens of original articles, book chapters, and reviews on DNA vaccines, tumor immunity, multiple myeloma, amyloidosis, and stem cell transplant. Dr. Cohen received his medical degree from the University of Pennsylvania, Philadelphia, where he also completed an internal medicine residency. He completed a hematology/oncology fellowship and was a research associate in the Laboratory of Tumor Immunology at Memorial Sloan-Kettering Cancer Center, New York.

Peter Voorhees, MD, is Director of Outreach and Clinical Operations for Hematologic Malignancies and a Member of the Plasma Cells Disorder Program at the Levine Cancer Institute in Charlotte, North Carolina. Dr. Voorhees is an internationally recognized thought leader in multiple myeloma whose research focuses on the clinical development of novel therapeutic strategies for the treatment of newly diagnosed and relapsed/refractory multiple myeloma. He is board certified in Hematology and a member of the American Society of Hematology, American Society of Clinical Oncology and International Myeloma Working Group. He is also a member of the Multiple Myeloma Committee of the Alliance Cooperative Group. He has published numerous original articles, reviews and book chapters in multiple myeloma. He received his medical degree from the University of Michigan, continued his postgraduate studies with an internal medicine residency/chief residency at the University of Wisconsin, and completed a hematology-oncology fellowship at the University of North Carolina at Chapel Hill. Prior to joining the Levine Cancer Institute, he was an Associate Professor in the Department of Internal Medicine, Division of Hematology-Oncology, at the University of North Carolina at Chapel Hill where he led their Multiple Myeloma Program.
Location
Charlotte, NC
Charlotte, NC, USA
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org







Get the Latest Multiple Myeloma Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.